STOCK TITAN

Royalty Pharma plc (RPRX) CFO logs equity award and 18,500-share gift

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Royalty Pharma plc EVP & CFO Terrance P. Coyne reported two equity changes. On August 5, 2026, an exempt acquisition under Rule 16b-3 delivered 11,002 Class A Ordinary Shares through settlement of Equity Performance Awards to TPC RP EPA1 LLC. On August 7, 2026, an indirect bona fide gift transferred 18,500 Class E Ordinary Shares, leaving 1,788,777 Class E shares indirectly held; these Class E shares are subject to vesting and are ultimately convertible into Class A Ordinary Shares. Coyne and related vehicles also hold limited partnership interests exchangeable into 6,448,180 Class A Ordinary Shares, plus additional direct and indirect Class A positions.

Positive

  • None.

Negative

  • None.
Insider Coyne Terrance P.
Role EVP & CFO
Type Security Shares Price Value
Gift Class E Ordinary Shares F2 18,500 $0.00 $0.00
Grant/Award Class A Ordinary Shares F1 11,002 $0.00 $0.00
holding Class A Ordinary Shares -- -- --
holding Class A Ordinary Shares -- -- --
holding Class A Ordinary Shares -- -- --
holding Class A Ordinary Shares -- -- --
Holdings After Transaction: Class E Ordinary Shares — 1,788,777 shares (Indirect, See Footnote (2)); Class A Ordinary Shares — 11,002 shares (Indirect, TPC RP EPA1 LLC); Class A Ordinary Shares — 24,170 shares (Indirect, By Spouse's IRA); Class A Ordinary Shares — 23,270 shares (Indirect, By IRA); Class A Ordinary Shares — 1,500 shares (Direct); Class A Ordinary Shares — 1,450 shares (Indirect, By Spouse)
Footnotes (2)
  1. F1. Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.
  2. F2. No Class E Ordinary Shares of RPH ("Class E Shares") are being converted by the Reporting Person. Class E Shares are subject to vesting conditions. Once vested, the Class E Shares may be converted at any time into an equivalent number of Class B ordinary shares of RPH ("Class B Shares") on a one-for-one basis, and there is no expiration date for such conversion. Each Class B Share may be converted at any time into an equivalent number of Class A ordinary shares of the Issuer on a one-for-one basis and there is no expiration date for such conversion.
Equity award shares 11,002 Class A Ordinary Shares Exempt acquisition in settlement of Equity Performance Awards on August 5, 2026
Gifted Class E shares 18,500 Class E Ordinary Shares Bona fide gift of derivative interests on August 7, 2026
Class E shares remaining 1,788,777 Class E Ordinary Shares Indirect Class E holdings after the reported bona fide gift
Exchangeable LP interests 6,448,180 Class A Ordinary Shares Limited partnership interests exchangeable into Class A shares held by Coyne and family vehicles
Spouse's IRA Class A holdings 24,170 Class A Ordinary Shares Indirect Class A holdings by spouse's IRA as of August 5, 2026
bona fide gift financial
"transaction_code_description": "Bona fide gift""
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
Rule 16b-3 financial
"Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
Equity Performance Awards financial
"in connection with the settlement of Equity Performance Awards."
Class E Ordinary Shares financial
"No Class E Ordinary Shares of RPH ("Class E Shares") are being converted"
limited partnership interests financial
"hold limited partnership interests in RPI US Partners 2019, LP exchangeable"
An ownership stake in a limited partnership gives an investor the role of a limited partner who provides capital but does not run day-to-day operations; a separate general partner manages the business. It matters because limited partners share profits, losses, and tax benefits but generally cannot lose more than they invested and have little control or liquidity—think of it like quietly funding a small business while someone else manages it, with potential return and risk tied to the venture’s performance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider equity transactions did Royalty Pharma (RPRX) CFO Terrance P. Coyne report?

Terrance P. Coyne reported an exempt acquisition of 11,002 Class A Ordinary Shares and an indirect bona fide gift of 18,500 Class E Ordinary Shares. The acquisition settled Equity Performance Awards, while the gift reduced but did not eliminate his indirect Class E holdings.

How many Royalty Pharma (RPRX) Class A shares did Coyne acquire in the latest filing?

Coyne reported acquiring 11,002 Class A Ordinary Shares indirectly via TPC RP EPA1 LLC. This exempt transaction occurred on August 5, 2026, in connection with the settlement of Equity Performance Awards and was reported as an acquisition under Rule 16b-3.

What was the size of Terrance P. Coyne’s bona fide gift reported at RPRX?

The filing reports a bona fide gift of 18,500 Class E Ordinary Shares as a derivative transaction. After this August 7, 2026 gift, Coyne continued to indirectly hold 1,788,777 Class E shares that are subject to vesting and later conversion rights.

What additional Royalty Pharma (RPRX) exposure do Coyne and his family vehicles have?

Coyne and family vehicles hold limited partnership interests in RPI US Partners 2019, LP exchangeable into 6,448,180 Class A Ordinary Shares. They also report several direct and indirect Class A holdings, including IRA and spouse IRA accounts, alongside the equity award settlement shares.

How are the new Class A shares for Royalty Pharma (RPRX) CFO classified in the filing?

The 11,002 newly reported Class A Ordinary Shares are classified as an exempt acquisition under Rule 16b-3. They arose from settlement of Equity Performance Awards and are held indirectly through TPC RP EPA1 LLC rather than in Coyne’s direct personal account.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Coyne Terrance P.

(Last)(First)(Middle)
C/O ROYALTY PHARMA PLC
110 EAST 59TH STREET

(Street)
NEW YORK NEW YORK 10022

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Royalty Pharma plc [ RPRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Ordinary Shares08/05/2026A11,002(1)A$011,002ITPC RP EPA1 LLC
Class A Ordinary Shares24,170IBy Spouse's IRA
Class A Ordinary Shares23,270IBy IRA
Class A Ordinary Shares1,500D
Class A Ordinary Shares1,450IBy Spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Class E Ordinary Shares(2)08/07/2026G18,500 (2) (2)Class A Ordinary Shares18,500(2)$01,788,777(2)ISee Footnote (2)
Explanation of Responses:
1. Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.
2. No Class E Ordinary Shares of RPH ("Class E Shares") are being converted by the Reporting Person. Class E Shares are subject to vesting conditions. Once vested, the Class E Shares may be converted at any time into an equivalent number of Class B ordinary shares of RPH ("Class B Shares") on a one-for-one basis, and there is no expiration date for such conversion. Each Class B Share may be converted at any time into an equivalent number of Class A ordinary shares of the Issuer on a one-for-one basis and there is no expiration date for such conversion.
Remarks:
In addition to the Class A Ordinary Shares disclosed above, the Reporting Person and family vehicles controlled by the Reporting Person hold limited partnership interests in RPI US Partners 2019, LP exchangeable into 6,448,180 Class A Ordinary Shares.
/s/ Sean Weisberg, as Attorney-in-Fact for Terrance P. Coyne08/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)